Patient capital

Here is a draft definition for patient capital:

Patient capital is money invested or lent with the understanding that returns will come slowly, if at all, in the short term. It prioritises long-term social or environmental impact over quick financial profit.

Conventional finance tends to expect relatively fast returns. Banks want loans repaid on a set schedule. Equity investors often want to see growth and returns within a few years. This timeline can be difficult for social enterprises, which are often working on complex problems that take time to shift, building trust with communities that have been let down before, or employing people who need significant support before they become confident, productive workers. Patient capital works differently. It gives an organisation the time and space to grow, test ideas, learn from what is not working, and build a sustainable business model without being forced to cut corners on its mission in order to meet short-term financial obligations. Patient capital can take many forms, including long-term loans at low or zero interest, equity investment that does not demand rapid returns, grants that are paid over multiple years, or convertible notes, which are loans that can convert into a share of ownership under agreed conditions.

In Australia, patient capital is increasingly recognised as one of the most important enablers for the social enterprise sector. Organisations working in areas such as employment for people facing significant disadvantage, affordable housing, community health, or First Nations economic development often need years to build relationships, develop their model, and demonstrate results. Philanthropic foundations such as the Paul Ramsay Foundation, the Westpac Foundation, and the Lord Mayor's Charitable Foundation have moved toward longer funding cycles and below-market loans in recognition of this reality. Impact Investing Australia works to grow the supply of patient capital from institutional investors, including superannuation funds, to mission-aligned organisations. Some state governments have also begun to offer longer-term, outcomes-linked funding arrangements that reflect the time horizons social enterprises actually need.

The main tension with patient capital is that it can be hard to find and harder to secure. Many funders still operate on annual grant cycles or expect commercial returns on investment, which does not suit the reality of most social enterprises. There is also a risk that patient capital, precisely because it does not demand immediate performance, can reduce the pressure on organisations to make hard decisions about sustainability. The availability of forgiving capital is not a substitute for a sound business model. For social enterprises seeking patient capital, it is important to be clear about the outcomes being pursued, realistic about the timeline for achieving them, and transparent with funders and investors about progress. For First Nations social enterprises in particular, patient capital that is genuinely patient, flexible, and community-controlled is essential to supporting self-determined economic development on terms that respect cultural values and community priorities.